← Leaderboards
Matcheri S. Keshavan
University Of Pittsburgh At Pittsburgh
$24,647,808
Attributed
$29,453,313
Total exposure
19
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$29,453,313 · 19
By mechanism
R01$25,605,985 · 11
P50$1,794,956 · 1
K02$647,590 · 1
R34$553,500 · 1
R21$481,765 · 1
M01$369,517 · 4
Top collaborators
- Lawrence H Yang7 shared
- Michael Robert Phillips6 shared
- Dara S Manoach5 shared
- William Seth Stone3 shared
- John Gabrieli2 shared
- Larry J Seidman2 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Cameron S. Carter$36,474,007
- Jay W Pettegrew$10,061,848
- John A Sweeney$9,455,711
- Beatriz Luna$30,087,219
- Erika E Forbes$15,246,225
Others in their field
Top investigators on “Schizophrenia”
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$104,668,216
- Raquel E Gur · University Of Pennsylvania$60,189,770
- Mark J Daly · Broad Institute, Inc.$48,989,393
- John M Kane · Long Island Jewish Medical Center$45,235,871
- Carrie E Bearden · University Of California Los Angeles$42,025,230
- Scott W Woods · Yale University$41,221,536
Research focus
SchizophreniaCognitionSamplingNeurobiologyBrainPsychotic DisordersHuman SubjectSymptomsDiagnosticCognitiveBasePhenotypeAntipsychotic AgentsStructureMagnetic Resonance ImagingDiagnosisParticipantProceduresBiological MarkersSubgroupChronicRecruitment ActivitySitePublic Health Relevance
Grant awards (78)
4/5: Antipsychotic Response to Clozapine in B-SNIP Biotype-1 (CLOZAPINE)$274,938
R01 · FY2025 · MH · contact PI
Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services (BICEPS)$228,636
R01 · FY2025 · MH · contact PI
4/5: Antipsychotic Response to Clozapine in B-SNIP Biotype-1 (CLOZAPINE)$274,991
R01 · FY2024 · MH · contact PI
Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services (BICEPS)$259,136
R01 · FY2024 · MH · contact PI
Longitudinal trajectories in treated and untreated schizophrenia$515,068
R01 · FY2023 · MH
4/5: Antipsychotic Response to Clozapine in B-SNIP Biotype-1 (CLOZAPINE)$275,042
R01 · FY2023 · MH · contact PI
Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services (BICEPS)$259,136
R01 · FY2023 · MH · contact PI
Longitudinal trajectories in treated and untreated schizophrenia$549,823
R01 · FY2022 · MH
4/5: Antipsychotic Response to Clozapine in B-SNIP Biotype-1 (CLOZAPINE)$275,092
R01 · FY2022 · MH · contact PI
Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services (BICEPS)$234,136
R01 · FY2022 · MH · contact PI
Longitudinal trajectories in treated and untreated schizophrenia$641,743
R01 · FY2021 · MH
4/5: Antipsychotic Response to Clozapine in B-SNIP Biotype-1 (CLOZAPINE)$275,140
R01 · FY2021 · MH · contact PI
Sleep spindles in early course schizophrenia and first-degree relatives$554,584
R01 · FY2020 · MH · contact PI
Characterizing cognition across the lifespan in untreated psychosis in China$848,575
R01 · FY2019 · MH
4/5 Bipolar-Schizophrenia Network for Intermediate Phenotypes$206,917
R01 · FY2019 · MH · contact PI
Characterizing cognition across the lifespan in untreated psychosis in China$853,214
R01 · FY2018 · MH
Sleep spindles in early course schizophrenia and first-degree relatives$554,584
R01 · FY2018 · MH · contact PI
4/5 Bipolar-Schizophrenia Network for Intermediate Phenotypes$443,283
R01 · FY2018 · MH · contact PI
Characterizing cognition across the lifespan in untreated psychosis in China$602,559
R01 · FY2017 · MH
4/5 Bipolar-Schizophrenia Network for Intermediate Phenotypes$564,673
R01 · FY2017 · MH · contact PI
Sleep spindles in early course schizophrenia and first-degree relatives$554,584
R01 · FY2017 · MH · contact PI
Characterizing cognition across the lifespan in untreated psychosis in China$315,649
R01 · FY2017 · MH
Stability of Biotypes: a Longitudinal Evaluation$127,189
R01 · FY2017 · MH · contact PI
Adaptation of Cognitive Enhancement Therapy for persons at Psychosis High Risk$31,500
R34 · FY2017 · MH · contact PI
4/5 Bipolar-Schizophrenia Network for Intermediate Phenotypes$775,334
R01 · FY2016 · MH · contact PI
Sleep spindles in early course schizophrenia and first-degree relatives$624,775
R01 · FY2016 · MH · contact PI
Brain Imaging, Cognitive Enhancement and Early Schizophrenia$569,750
R01 · FY2016 · MH · contact PI
Adaptation of Cognitive Enhancement Therapy for persons at Psychosis High Risk$261,000
R34 · FY2016 · MH · contact PI
4/5 Bipolar-Schizophrenia Network for Intermediate Phenotypes$886,940
R01 · FY2015 · MH · contact PI
Sleep spindles in early course schizophrenia and first-degree relatives$712,694
R01 · FY2015 · MH · contact PI
Brain Imaging, Cognitive Enhancement and Early Schizophrenia$601,630
R01 · FY2015 · MH · contact PI
4/6 Psychosis and Affective Research Domains and Intermediate Phenotypes (PARDIP)$261,000
R01 · FY2015 · MH · contact PI
Adaptation of Cognitive Enhancement Therapy for persons at Psychosis High Risk$261,000
R34 · FY2015 · MH · contact PI
Brain Imaging, Cognitive Enhancement and Early Schizophrenia$607,598
R01 · FY2014 · MH · contact PI
4/6 Psychosis and Affective Research Domains and Intermediate Phenotypes (PARDIP)$261,000
R01 · FY2014 · MH · contact PI
Brain Imaging, Cognitive Enhancement and Early Schizophrenia$600,823
R01 · FY2013 · MH · contact PI
4/6 Psychosis and Affective Research Domains and Intermediate Phenotypes (PARDIP)$261,000
R01 · FY2013 · MH · contact PI
Brain Function and Structure in Young Children at Familial Risk for Schizophrenia$205,747
R21 · FY2013 · MH
Brain Imaging, Cognitive Enhancement and Early Schizophrenia$674,582
R01 · FY2012 · MH · contact PI
Brain Function and Structure in Young Children at Familial Risk for Schizophrenia$276,018
R21 · FY2012 · MH
Bipolar & Schizophrenia Consortium for Parsing Intermediate Phenotypes$770,399
R01 · FY2010 · MH · contact PI
Bipolar & Schizophrenia Consortium for Parsing Intermediate Phenotypes$801,520
R01 · FY2009 · MH · contact PI
Bipolar & Schizophrenia Consortium for Parsing Intermediate Phenotypes$813,845
R01 · FY2008 · MH · contact PI
Brain Maturation and Vulnerability to Schizophrenia$509,142
R01 · FY2008 · MH · contact PI
Bipolar & Schizophrenia Consortium for Parsing Intermediate Phenotypes$809,536
R01 · FY2007 · MH · contact PI
CORE--CLINICAL$232,528
P50 · FY2007 · MH · contact PI
Brain Maturation and Vulnerability to Schizophrenia$650,231
R01 · FY2006 · MH · contact PI
CORE--CLINICAL$227,599
P50 · FY2006 · MH · contact PI
Brain Maturation and Vulnerability to Schizophrenia$631,253
R01 · FY2005 · MH
Rehabilitation, Brain Function and Early Schizophrenia$451,932
R01 · FY2005 · MH
CORE--CLINICAL$221,630
P50 · FY2005 · MH
BRAIN MATURATION AND VULNERABILITY TO SCHIZOPHRENIA$117,223
K02 · FY2005 · MH
BRAIN CIRCUITRY AND COGNITION IN PSYCHOSIS$22,984
M01 · FY2005 · RR
EFFECT OF QUETIAPINE ON DELTA SLEEP DEFICITS IN SCHIZOPHRENIA$9,993
M01 · FY2005 · RR
Brain Maturation and Vulnerability to Schizophrenia$658,617
R01 · FY2004 · MH
Rehabilitation, Brain Function and Early Schizophrenia$574,622
R01 · FY2004 · MH
Neurobiological Study of Schizophrenia$307,541
M01 · FY2004 · RR
CORE--CLINICAL$220,726
P50 · FY2004 · MH
BRAIN MATURATION AND VULNERABILITY TO SCHIZOPHRENIA$123,214
K02 · FY2004 · MH
BRAIN MATURATION AND VULNERABILITY TO SCHIZOPHRENIA$55,484
K02 · FY2004 · MH
Brain Circuitry and Cognition in Psychosis$17,552
M01 · FY2004 · RR
Quetiapine in Delta Sleep Deficits in Schizophrenia$11,447
M01 · FY2004 · RR
Rehabilitation, Brain Function and Early Schizophrenia$603,081
R01 · FY2003 · MH
Brain Maturation and Vulnerability to Schizophrenia$545,076
R01 · FY2003 · MH
CORE--CLINICAL$253,377
P50 · FY2003 · MH
BRAIN MATURATION AND VULNERABILITY TO SCHIZOPHRENIA$117,223
K02 · FY2003 · MH
Rehabilitation, Brain Function and Early Schizophrenia$633,725
R01 · FY2002 · MH
CORE--CLINICAL$228,564
P50 · FY2002 · MH
BRAIN MATURATION AND VULNERABILITY TO SCHIZOPHRENIA$117,223
K02 · FY2002 · MH
OCULOMOTOR/ WORKING MEMORY DISTURBANCES IN SCHIZOPHRENIA$0
M01 · FY2002 · RR
OCULOMOTOR/ WORKING MEMORY DISTURBANCES IN SCHIZOPHRENIA$0
M01 · FY2002 · RR
Rehabilitation, Brain Function and Early Schizophrenia$398,948
R01 · FY2001 · MH
CORE--CLINICAL$228,564
P50 · FY2001 · MH
BRAIN MATURATION AND VULNERABILITY TO SCHIZOPHRENIA$117,223
K02 · FY2001 · MH
OCULOMOTOR/ WORKING MEMORY DISTURBANCES IN SCHIZOPHRENIA$0
M01 · FY2001 · RR
EEG SLEEP AND NEURODEVELOPMENT IN SCHIZOPHRENIA$228,240
R01 · FY2000 · MH
CORE--CLINICAL$181,968
P50 · FY2000 · MH
OCULOMOTOR/ WORKING MEMORY DISTURBANCES IN SCHIZOPHRENIA$0
M01 · FY2000 · RR